Equioxx Injection is a drug owned by BOEHRINGER LNGELHEIM ANIMAL HEALTH USA, INC. It is protected by 2 US drug patents filed from 2016 to 2018. All patents have expired. Details of Equioxx Injection’s patents and their expiration are given below.
| Drug Patent Number | Drug Patent Expiry | Status |
|---|---|---|
 | ||
| US6020343 | 09 Oct, 2016 | Expired |
Exclusivity Information
Equioxx Injection holds 1 exclusivity out of which 1 has expired. Details of Equioxx Injection's exclusivity codes and their expiration dates are given below.
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| NCI | Aug 20, 2013 |
About Equioxx Injection
Equioxx Injection is a drug
owned by BOEHRINGER LNGELHEIM ANIMAL HEALTH USA, INC.
Equioxx Injection uses
Firocoxib as the active
ingredient.
Active Ingredient:
Equioxx Injection uses
Firocoxib as the active ingredient.
Check out other Drugs and Companies using
Firocoxib ingredient.